表3
患者BMD在Dmab (BP-naive和BP-prior)和BP患者治疗不转向Dmab(对照组)。
|
|
基底 |
12米 |
变化(%) |
|
| BP-naive |
|
|
|
| LS BMD (g / cm2) |
0.866±0.017 |
0.912±0.018# |
↑5.31 |
| FN (g / cm2) |
0.780±0.017 |
0.811±0.018# |
↑3.97 |
| (克/厘米2) |
0.749±0.015 |
0.772±0.014# |
↑3.07 |
|
| BP-prior |
|
|
|
| LS BMD (g / cm2) |
0.861±0.008 |
0.908±0.008 |
↑5.46 |
| FN (g / cm2) |
0.735±0.008 |
0.766±0.009 |
↑4.22 |
| (克/厘米2) |
0.736±0.006 |
0.757±0.007 |
↑2.85 |
|
| 对照组 |
|
|
|
| LS BMD (g / cm2) |
0.906±0.009 |
0.923±0.010θ |
↑1.88% |
| FN (g / cm2) |
0.745±0.009 |
0.752±0.008 |
ns |
| (克/厘米2) |
0.756±0.012 |
0.758±0.013 |
ns |
|
|
与BP-naive基底显著差异;与BP-prior基底显著差异;与对照组基底显著差异。
|
